Diclofenac maximum recommended dose reduced from 150 mg to 100 mg dailyLower dose intended to improve cardiovascular safety of systemic diclofenac products. Xeljanz: first oral JAK inhibitor for rheumatoid arthritisUsed for moderately to severely active disease in adults with an inadequate response to methotrexate. Actemra: new subcutaneous formulation for rheumatoid arthritis Patients can be taught to self-inject at home, using prefilled syringes FPs benefit from pharmacist education on rheumatoid arthritis Feedback from family doctors suggested one-on-one academic detailing provided by pharmacists had greater educational value than traditional CME. Autism risk higher in children of women with lupus Link may have implications for pregnancy planning Shoppers Drug Mart unveils new arthritis screening program Do PPIs increase hip fracture risk? Gastroenterology group updates its position on proton pump inhibitor therapy and the risk of hip fracture. Orencia now available in subcutaneous formulation Rheumatoid arthritis drug now available in two formats. Lupus patients often fail to get Pap tests Screening falls short despite higher risk for cervical dysplasia Brain ‘awry’ in fibromyalgia Scans help explain why these patients don’t respond well to opioids First Previous 13 14 15 16 17 Next Last
